ARCHIVES

Oncotype DX Cancer Test Can Predict Recurrence

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | November 25, 2011

Download PDF Visit The Full Archive

Related Articles

New Research Training Act May Permit NCI To Help fill Clinical Gaps In Radiotherapy, Medical Oncology

July 26, 1974

Genasense Added To Chemo Improves Responses in CLL

December 31, 2004

NCI FY 1991 Operating Budget Outlined In Chart

December 7, 1990

“Dollars For Docs” Database Of Pharma Payments Posted By News Organization

October 22, 2010

Concepts Approved For Developmental Therapeutics Program

June 19, 1987

FDA Approves Bexxar For Non-Hodgkin’s Lymphoma

June 27, 2003